The evaluation of Tragacanth on the treatment of constipation during pregnancy

The comparison of the effect of Tragacanth and Psyllium on treatment of severe constipation in the patients at the third trimester of pregnancy

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20140525017827N9

Enrollment

Registered

2020-05-02

Start date

2020-04-19

Completion date

Unknown

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Constipation in pregnancy. Constipation

Interventions

Intervention 1: Intervention group: 32 patients will use tragacanth three times a day for one week each time. Intervention 2: Intervention group: 32 patients will use psyllium three times a day for a

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Pregnant patients with severe constipation Homogeneous in terms of age, number of pregnancies, gestational age and .BMI

Exclusion criteria

Exclusion criteria: Sensitivity to Psyllium and Tragacanth Have a history of kidney disease, thyroid and diabetes Multi-fetal pregnancy IBS or IBD patients Patients developed with hemorrhoids

Design outcomes

Primary

Measure	Time frame
ROMEII criteria defined constipation by having two or more of 4 main complains. Timepoint: Evaluation of severity of constipation and its scale before treatment and 1 week post treatment. Method of measurement: Constipation assessment scale.	—

Secondary

Measure	Time frame
Improvement of quality of life. Timepoint: Quality of life at the beginning and end of treatment. Method of measurement: Quality of life sf_36 questionare.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNarjes Montazeri

Shiraz University of Medical Sciences

montazeri.narsis9@gmail.com+98 71 3233 2365

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026